The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Reduction of suicidality during clozapine treatment of neuroleptic- resistant schizophrenia: impact on risk-benefit assessment
Abstract
OBJECTIVE: Suicide has been reported to occur in 9%-13% of schizophrenic patients. It has been suggested that neuroleptic-resistant or neuroleptic-intolerant schizophrenic patients are at higher risk for suicide than neuroleptic-responsive patients. Clozapine is the treatment of choice for neuroleptic-resistant patients, but its use has been greatly limited because of its ability to cause potentially fatal agranulocytosis. The purpose of this study was to compare the suicidality of neuroleptic-resistant and neuroleptic-responsive patients and to determine if clozapine treatment decreased suicidality in the former group. METHOD: Prior episodes of suicidality were assessed in a total of 237 neuroleptic-responsive and 184 neuroleptic-resistant patients with schizophrenia or schizoaffective disorder. Eighty-eight of the neuroleptic-resistant patients were treated with clozapine and prospectively evaluated for suicidality for periods of 6 months to 7 years. RESULTS: There was no significant difference in prior suicidal episodes between neuroleptic-responsive and neuroleptic-resistant patients. Clozapine treatment of the neuroleptic-resistant patients during the follow-up period resulted in markedly less suicidality. The number of suicide attempts with a high-probability of success decreased from five to zero. This decrease in suicidality was associated with improvement in depression and hopelessness. CONCLUSIONS: These results suggest a basis for reevaluation of the risk-benefit assessment of clozapine, i.e., that the overall morbidity and mortality of patients with neuroleptic-resistant schizophrenia are less with clozapine treatment than with typical neuroleptic drugs because of less suicidality. This conclusion also has implications for increasing the use of clozapine with neuroleptic-responsive patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.559 · Cited by 1,723
Analysis of Ordinal Categorical Data.
Tsutakawa, R. K., & Agresti, A. (1985) · Journal of the American Statistical Association · doi:10.2307/2288509 · Cited by 1,628
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
A General Methodology for the Analysis of Experiments with Repeated Measurement of Categorical Data
Koch, G. G., Landis, J. R., Freeman, J. L., Freeman, D. H., & Lehnen, R. G. (1977) · Biometrics · doi:10.2307/2529309 · Cited by 609
Hopelessness, Depression, and Attempted Suicide
MINKOFF, K., BERGMAN, E., BECK, A. T., & BECK, R. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.4.455 · Cited by 527
CONDITIONS PREDISPOSING TO SUICIDE: A REVIEW
MILES, C. P. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197704000-00002 · Cited by 504
Suicide, and Other Causes of Death, Following Attempted Suicide
Hawton, K., & Fagg, J. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.3.359 · Cited by 441
Research works printed but not linked: 22
- 1950, Bleuler E: Dementia Praecox or the Group of Schizophrenias (191 1). Translated by ZinkinJ
- Niskanen P, 1973, Psychiatria Fennica, 223
- Bleuler M, 1978, The Schizophrenic Disorders: Long-Term and Family Studies
- Ehlinger R, 1975, Acta Psychiatr Scand (Suppl), 260, 64
- Kreitman, 1977, Parasuicide
- Krupp P, 1989, Psychopharmacology (Berl), 99, 18, 10.1007/BF00442575 · doi:10.1007/bf00442575
- Rhodes HM, 1988, Psychopharmacol Bull, 10, 101
- User's Guide, 1990, version 6
- 10.2307/2529309 · DOI · Paper page
- 10.1159/000284650 · doi:10.1159/000284650
- Yasuden M, 1992, Seishin Shinkeigaku Zasshi, 94, 135
- Sletten LW, 1972, Dis Nerv Syst, 33, 328
- Beisser A, 1961, Dis Nerv Syst, 22, 365
- 10.1097/00004714-199110000-00019 · doi:10.1097/00004714-199110000-00019
- Denber HC, 1957, Dis Nerv Syst, 18, 35
- So, 1969, Dc Alarcon R
- 10.1177/070674378302800407 · doi:10.1177/070674378302800407
- Meltzer HY, 1990, Hosp Community Psychiatry, 41, 892
- Beck RE, 1988, Hosp Community Psychiatry, 39, 1269
- 10.1176/ajp.133.2.208 · doi:10.1176/ajp.133.2.208
- Solomon P, 1981, Hosp Community Psychiatry, 32, 405
- 10.1192/bjp.148.3.310 · doi:10.1192/bjp.148.3.310
Cited by
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Self-citationNeurobiology of suicidal behaviour
Mann, J. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1220 · Cited by 1,260
EPPIC: An Evolving System of Early Detection and Optimal Management
McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.305 · Cited by 937
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Mortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., Green-Paden, L. D., Tenhula, W. N., Boerescu, D., Tek, C., et al. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007071 · Cited by 757
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
A Current Perspective of Suicide and Attempted Suicide
Mann, J. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00010 · Cited by 568
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp130 · Cited by 499
Treatment-Resistant Schizophrenia - The Role of Clozapine
Meltzer, H. Y. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113338 · Cited by 491
Khan, A., Warner, H. A., & Brown, W. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.311 · Cited by 477
Update on Typical and Atypical Antipsychotic Drugs
Meltzer, H. Y. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050911-161504 · Cited by 433
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
Siris, S. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1379 · Cited by 427
Siris, S. G. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500209 · Cited by 412
Suicide risk in schizophrenia: learning from the past to change the future
Pompili, M., Amador, X. F., Girardi, P., Harkavy-Friedman, J., Harrow, M., Kaplan, K., Krausz, M., Lester, D., Meltzer, H. Y., Modestin, J., et al. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-10 · Cited by 358
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Management of treatment resistance in schizophrenia
Conley, R. R., & Kelly, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01271-9 · Cited by 352
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guide, Falkai, P., Wobrock, T., Lieberman, J., et al. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 331
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00010 · Cited by 328
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia
Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324
Angst, J., Angst, F., Gerber-Werder, R., & Gamma, A. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929488 · Cited by 318
Yovell, Y., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherov, J., Lotan, A., Rigbi, A., & Panksepp, J. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040535 · Cited by 311
Sur, C., Mallorga, P. J., Wittmann, M., Jacobson, M. A., Pascarella, D., Williams, J. B., Brandish, P. E., Pettibone, D. J., Scolnick, E. M., & Conn, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835612100 · Cited by 294
Suicidal risk during treatment with clozapine: a meta-analysis
Hennen, J., & Baldessarini, R. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.05.015 · Cited by 287
Active monitoring of 12760 clozapine recipients in the UK and Ireland: Beyond pharmacovigilance
Munro, J., O'Sullivan, D., Andrews, C., Arana, A., Mortimer, A., & Kerwin, R. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.6.576 · Cited by 285
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Suicide: An Indian perspective
Radhakrishnan, R., & Andrade, C. (2012) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.104793 · Cited by 269
Brent, D. A., Greenhill, L. L., Compton, S., Emslie, G., Wells, K., Walkup, J. T., Vitiello, B., Bukstein, O., Stanley, B., Posner, K., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b5dbe4 · Cited by 262
A systematic review of the evidence of clozapine's anti-aggressive effects
Frogley, C., Taylor, D., Dickens, G., & Picchioni, M. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100201x · Cited by 252
Suppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1164 · Cited by 238
McClay, J. L., Adkins, D. E., Åberg, K., Bukszár, J., Khachane, A. N., Keefe, R. S. E., Perkins, D. O., McEvoy, J. P., Stroup, T. S., Vann, R. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.193 · Cited by 124
Critical appraisal of major depression with suicidal ideation
Pompili, M. (2019) · Annals of General Psychiatry · doi:10.1186/s12991-019-0232-8 · Cited by 100
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Pompili, M., Baldessarini, R., Forte, A., Erbuto, D., Serafini, G., Fiorillo, A., Amore, M., & Girardi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101700 · Cited by 78
Determining the optimal dose of haloperidol in first-episode psychosis
Oosthuizen, P., Emsley, R. A., Turner, J., & Keyter, N. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500403 · Cited by 48
Ahearn, E. P., Chen, P., Hertzberg, M., Cornette, M., Suvalsky, L., Cooley-Olson, D., Swanlund, J., Eickhoff, J., Becker, T., & Krahn, D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.015 · Cited by 45
The role of psychopharmacology in suicide prevention
Saunders, K. E. A., & Hawton, K. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00000427 · Cited by 34
Lin, C., Chung, C., Chen, L., & Chien, W. (2019) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12497 · Cited by 7
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1995-02-01
- Volume
- 152
- Issue
- 2
- Pages
- 183-190
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W80598485
- Cited by
- 436
- References
- 55
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.